Piramal Pharma Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 81,711.6 million compared to INR 70,815.5 million a year ago. Revenue was INR 83,465.5 million compared to INR 73,066.6 million a year ago.

Net income was INR 178.2 million compared to net loss of INR 1,864.6 million a year ago. Basic earnings per share from continuing operations was INR 0.14. Diluted earnings per share from continuing operations was INR 0.14.